Cargando…
Beta-Blockers in the Critically Ill: Friend or Foe?
[Figure: see text]
Autor principal: | Senussi, Mourad H. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the American College of Cardiology Foundation. Published by Elsevier.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9458104/ https://www.ncbi.nlm.nih.gov/pubmed/34474732 http://dx.doi.org/10.1016/j.jacc.2021.07.006 |
Ejemplares similares
-
Beta-blockers: friend or foe in asthma?
por: Arboe, Bente, et al.
Publicado: (2013) -
Glutamine supplementation in the critically ill: friend or foe?
por: Oudemans-van Straaten, Heleen M, et al.
Publicado: (2014) -
Beta-Hydroxybutyrate, Friend or Foe for Stressed Hearts
por: Chu, Yuxin, et al.
Publicado: (2021) -
miRNAs in the Beta Cell—Friends or Foes?
por: Karagiannopoulos, Alexandros, et al.
Publicado: (2023) -
ZEB Proteins in Leukemia: Friends, Foes, or Friendly Foes?
por: Soen, Bieke, et al.
Publicado: (2018)